Delivery Order SPE2DB25D3005-SPE2DB25FQHFX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (quantity 60) on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Calquence is a pharmaceutical product used in the treatment of hematologic...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 for 60 tablets of Calquence 100 mg on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Calquence is a prescription medication used in oncology treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg on September 18, 2025, with an ultimate completion date of October 9, 2025. This is a firm fixed price, non-set-aside contract utilizing competitively awarded delivery order pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Calquence is a targeted therapy pharmaceutical used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Calquence is a prescription medication used in the...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Calquence 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $5,593.77 and an ultimate completion date of September 22, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed price contract valued at $11,187.56, with completion expected by October 6, 2025. This non-set-aside award reflects competitive procurement and represents a small-value delivery order within AmerisourceBergen's broader relationship with the federal government. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation has an ultimate completion date of September 16, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count) valued at $5,593.77 under a firm fixed-price contract. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location, supplying this...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQHFXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count package) on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Calquence is a prescription oncology medication used in the treatment of certain blood cancers, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's established presence as a prime vendor through the DLA's pharmaceutical supply chain demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/28/25 |